The lifetime risks of cancer from medical radiation may be overemphasized relative to more immediate health risks, according to a new clinical study published online in the journal Radiology.
Philips Royal Electronics and Unfors RaySafe AB announced the signing of a Joint Development Agreement that will see the development of the next generation Philips DoseAware system, with the aim of offering seamless access and communication between Philips DoseAware and Philips Allura interventional X-ray systems.
MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new clinical study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder.
In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...
At RSNA 2012 Montage Healthcare Solutions and Radimetrics demonstrated the benefits of correlating dose information with Montage clinical report search results.
Double Black Imaging and Wide Corp. demonstrated a full line of auto-calibrating LED displays. The new line includes a 4 MP color, 6 MP color, 10 MP monochrome, 3 MP monochrome, 3 MP color and 5 MP monochrome.
Imaging Diagnostic Systems Inc. announced that Clinical Imaging has reviewed and accepted a paper that evaluates the results of CTLM(R) and mammography when imaging dense breasts.
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the ...
Agfa HealthCare demonstrated its new Impax Radiation Exposure Monitoring (REM) solution at the 2012 RSNA meeting in Chicago. Impax REM provides an automated way to collect, organize and analyze a patient’s radiation exposure data. Radiation exposure is of interest to all players in a patient’s treatment, from the patient himself, to the referring physician, to the radiology department, to regulatory bodies and to researchers. Information on radiation exposure levels can support the referring physician in making a better-informed decision, while allowing the radiology department to use best practices and to conform to regulations, for example.
The introduction of new technology into the magnetic resonance imaging (MRI) landscape has changed the face of the market segment over the last year. Although MRI satisfaction scores tend to cluster together, the differences are in the details, according to recent findings from healthcare technology research firm KLAS in its report MRI 2012: Broadening Your Field of View.
RamSoft announced its partnership with Digisonics to offer integrated, vendor-neutral cardiac post-processing and structured reporting for all cardiovascular modalities. Digisonics was recently named Best in KLAS for the Cardiology market segment for the fifth consecutive year.
December 28, 2012 — At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, 3Disc introduced its next-generation QuantorMed+ and QuantorVet+ imaging software. Quantor+ provides facilities using 3Disc’s family of FireCR+ medical and veterinary readers with optimized image acquisition, processing and management capabilities.
December 28, 2012 — Elekta announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Clarity 4D Monitoring software. Physicians will now be able to monitor the motion of the prostate and surrounding tissues and organs – in real-time and with sub-millimeter accuracy – during the delivery of therapeutic radiation beams.
December 28, 2012 — Accuray Inc. announced clinical findings using noninvasive CyberKnife stereotactic body radiation therapy (SBRT) for the treatment of prostate cancer. Two studies were presented at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston at a prostate-focused press conference, for which the use of CyberKnife SBRT for prostate cancer represented half of the press conference’s focus.
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and ...
December 27, 2012 — A new way to use MRI scans may help determine whether dementia is Alzheimer’s disease or another type of dementia, according to new research published in the Dec. 26, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
Siemens Healthcare has announced the availability of its ImageScapes customized thematic healthcare environments, which are designed to calm and comfort patients of all ages and positively impact the patient experience.
Agfa HealthCare has launched the IMPAX Data Center (IDC) 3.0. This new version of Agfa HealthCare’s enterprise medical imaging repository, also called a vendor neutral archive (VNA), is PACS- and storage vendor-agnostic.
December 26 , 2012 — Congress last week affirmed its dedication to securing a sustainable, domestic supply of molybdenum-99 (Mo-99) as it passed the American Medical Isotope Production Act of 2011 (S.99). The bill, sponsored Sen. Jeff Bingaman (D-N.M.), chair of the Senate Committee on Energy and Natural Resources, and Sen. Lisa Murkowski (R-Ark), was passed out of the Senate by Unanimous Consent and referred to the House Subcommittee on Energy and Environment. S.99 was included in the Conference Agreement for the National Defense Authorization Act for fiscal year 2013. The president is expected to sign the final legislation.
At RSNA 2012, GE Healthcare focused attention on next-generation products and solutions in its computed tomography (CT) and Advantage Workstation (AW) businesses with the announcement of three scanners now available — the Optima CT660 FREEdom Edition, the Optima CT540 and the Discovery CT750 HD FREEdom Edition.
GE Healthcare introduced an expansion of the line of Caring Magnetic Resonance (MR) Suites, built by PDC, that now includes designs specific to GE’s Extremity Optima 430s MR scanner.
For men undergoing proton therapy for prostate cancer, fewer treatments with higher doses appear to be well tolerated, according to early clinical trial results. The trial, which continues to enroll patients, is evaluating using only 5 proton treatments given over 2 weeks for patients with low risk prostate cancer, a fraction of the 44 treatments typical in an 8-week standard course of therapy.
December 21, 2012 — Vacancy rates for radiation therapists declined in 2012, according to the American Society of Radiologic Technologists’ (ASRT) 2012 Radiation Therapy Staffing & Workplace Survey.